Results for tag: "C1 Inhibitor"

The C1 Inhibitor market is a segment of the Immune Disorders Drugs market, which focuses on treatments for conditions related to the immune system. C1 Inhibitor is a protein that helps regulate the immune system and is used to treat a variety of conditions, including hereditary angioedema, a rare genetic disorder that causes swelling of the face, extremities, and airways. C1 Inhibitor drugs are used to reduce the frequency and severity of attacks, as well as to prevent them from occurring. C1 Inhibitor drugs are typically administered through subcutaneous injections, and are available in both branded and generic forms. The market is highly competitive, with a number of companies offering C1 Inhibitor drugs. Some of the major players in the market include Shire, CSL Behring, Pharming Group, and ViroPharma. Show Less Read more